BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R; Multiple Sclerosis Outcome Assessments Consortium. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler 2017;23:704-10. [PMID: 28206828 DOI: 10.1177/1352458517690823] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 26.4] [Reference Citation Analysis]
Number Citing Articles
1 Ziemssen T, Hoffmann O, Klotz L, Schreiber H, Weber MS, Rauser B. Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA. JMIR Res Protoc 2020;9:e19598. [PMID: 32499214 DOI: 10.2196/19598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Khalil H, Rehan R, Al-Sharman A, El-Salem K. The clinical correlates of the chair sit to stand performance in people with multiple sclerosis. Physiother Theory Pract 2021;:1-12. [PMID: 34156901 DOI: 10.1080/09593985.2021.1931590] [Reference Citation Analysis]
3 Miller BJ, Kolobe TH, Larson RD, Pribble BA, Pardo G, James SA. Functional intermuscular reduction in spasticity for people with multiple sclerosis. Mult Scler J Exp Transl Clin 2022;8:20552173211061547. [PMID: 35024159 DOI: 10.1177/20552173211061547] [Reference Citation Analysis]
4 Bollaert RE, Motl RW. Aging With Multiple Sclerosis: An Agenda for Examining the Effects of Physical Activity Behavior. Topics in Geriatric Rehabilitation 2019;35:183-9. [DOI: 10.1097/tgr.0000000000000233] [Reference Citation Analysis]
5 Strzok S, Cleanthous S, Pompilus F, Cano SJ, Marquis P, Cohan S, Goldman MD, Kresa-Reahl K, Petrillo J, Castrillo-Viguera C, Cadavid D, Chen SY. Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study. Mult Scler J Exp Transl Clin 2018;4:2055217318783766. [PMID: 30090638 DOI: 10.1177/2055217318783766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Nasseri NN, Ghezelbash E, Zhai Y, Patra S, Riemann-Lorenz K, Heesen C, Rahn AC, Stellmann JP. Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months. PeerJ 2020;8:e9303. [PMID: 32612882 DOI: 10.7717/peerj.9303] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Hulst HE, Thompson AJ, Geurts JJ. The measure tells the tale: Clinical outcome measures in multiple sclerosis. Mult Scler 2017;23:626-7. [PMID: 28206813 DOI: 10.1177/1352458517690825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. Recovery of cognitive function after relapse in multiple sclerosis. Mult Scler 2021;27:71-8. [PMID: 31971066 DOI: 10.1177/1352458519898108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
9 Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol 2018;265:119-26. [PMID: 29159465 DOI: 10.1007/s00415-017-8676-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
10 Baird JF, Cederberg KL, Sikes EM, Silveira SL, Jeng B, Sasaki JE, Sandroff BM, Motl RW. Physical activity and walking performance across the lifespan among adults with multiple sclerosis. Multiple Sclerosis and Related Disorders 2019;35:36-41. [DOI: 10.1016/j.msard.2019.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
11 Hadouiri N, Monnet E, Gouelle A, Decavel P, Sagawa Y. Evaluation of Prolonged Walking in Persons with Multiple Sclerosis: Reliability of the Spatio-Temporal Walking Variables during the 6-Minute Walk Test. Sensors (Basel) 2021;21:3075. [PMID: 33925075 DOI: 10.3390/s21093075] [Reference Citation Analysis]
12 Goldman MD, LaRocca NG, Rudick RA, Hudson LD, Chin PS, Francis GS, Jacobs A, Kapoor R, Matthews PM, Mowry EM, Balcer LJ, Panzara M, Phillips G, Uitdehaag BMJ, Cohen JA; Multiple Sclerosis Outcome Assessments Consortium. Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data. Neurology 2019;93:e1921-31. [PMID: 31641014 DOI: 10.1212/WNL.0000000000008519] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 8.3] [Reference Citation Analysis]
13 Rhodes JK, Schindler D, Rao SM, Venegas F, Bruzik ET, Gabel W, Williams JR, Phillips GA, Mullen CC, Freiburger JL, Mourany L, Reece C, Miller DM, Bethoux F, Bermel RA, Krupp LB, Mowry EM, Alberts J, Rudick RA. Multiple Sclerosis Performance Test: Technical Development and Usability. Adv Ther 2019;36:1741-55. [PMID: 31054035 DOI: 10.1007/s12325-019-00958-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
14 Katirci-kirmaci Zİ, Adiguzel H, Erel S, Neyal AM, Neyal A, Ergun N. Validity and Reliability of The 3-Meter Backward Walk Test in Patients with Multiple Sclerosis. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103842] [Reference Citation Analysis]
15 Rao SM, Sokolowski M, Strober LB, Miller JB, Norman MA, Levitt N, Williams JR, de Moor C. Multiple Sclerosis Performance Test (MSPT): Normative Study of 428 Healthy Participants Ages 18 to 89. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103644] [Reference Citation Analysis]
16 Molenaar P, Strijbis E, van Munster C, Uitdehaag B, Kalkers N. ‘Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis.’. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103725] [Reference Citation Analysis]
17 Kalinowski A, Cutter G, Bozinov N, Hinman JA, Hittle M, Motl R, Odden M, Nelson LM. The timed 25-foot walk in a large cohort of multiple sclerosis patients. Mult Scler 2021;:13524585211017013. [PMID: 34100297 DOI: 10.1177/13524585211017013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Krbot Skorić M, Crnošija L, Gabelić T, Adamec I, Habek M. Relationship Between Sensory Dysfunction and Walking Speed in Patients With Clinically Isolated Syndrome: . Journal of Clinical Neurophysiology 2018;35:65-70. [DOI: 10.1097/wnp.0000000000000431] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Solanky BS, John NA, DeAngelis F, Stutters J, Prados F, Schneider T, Parker RA, Weir CJ, Monteverdi A, Plantone D, Doshi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS-SMART Investigators. NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study. AJNR Am J Neuroradiol 2020;41:2209-18. [PMID: 33154071 DOI: 10.3174/ajnr.A6809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
20 Jakimovski D, Kavak KS, Zakalik K, Bromley L, Ozel O, Qutab N, Eckert SP, Kolb C, Weinstock-Guttman B. A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis. Mult Scler J Exp Transl Clin 2022;8:20552173221099186. [PMID: 35571975 DOI: 10.1177/20552173221099186] [Reference Citation Analysis]
21 Simmatis LE, Jin AY, Taylor SW, Bisson EJ, Scott SH, Baharnoori M. The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics. Mult Scler J Exp Transl Clin 2020;6:2055217320964940. [PMID: 33149931 DOI: 10.1177/2055217320964940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ontaneda D. Progressive Multiple Sclerosis: . CONTINUUM: Lifelong Learning in Neurology 2019;25:736-52. [DOI: 10.1212/con.0000000000000727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Filli L, Sutter T, Easthope CS, Killeen T, Meyer C, Reuter K, Lörincz L, Bolliger M, Weller M, Curt A, Straumann D, Linnebank M, Zörner B. Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time. Sci Rep 2018;8:4984. [PMID: 29563533 DOI: 10.1038/s41598-018-22676-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
24 Arroyo González R. A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis. Expert Rev Neurother 2018;18:785-91. [PMID: 30235965 DOI: 10.1080/14737175.2018.1510772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gravesteijn AS, Beckerman H, de Jong BA, Hulst HE, de Groot V. Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial. BMC Neurol 2020;20:177. [PMID: 32393193 DOI: 10.1186/s12883-020-01765-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hamdy E, Talaat F, Said SM, Ramadan I, Marouf H, Hamdy MM, Sadallah H, Ashmawi GAH, Elsalamawy D. Diagnosing ‘transition’ to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103718] [Reference Citation Analysis]
27 Ontaneda D, Cohen JA, Amato MP. Clinical outcome measures for progressive MS trials. Mult Scler 2017;23:1627-35. [PMID: 29041863 DOI: 10.1177/1352458517729465] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
28 Stepanova A, Makshakov G, Kulyakhtin A, Kalinin I, Feys P, Evdoshenko E. Improvement of gait and balance in patients with multiple sclerosis after multidisciplinary physical rehabilitation: Analysis of real-world data in Russia. Multiple Sclerosis and Related Disorders 2022;59:103640. [DOI: 10.1016/j.msard.2022.103640] [Reference Citation Analysis]
29 Hu W, Combden O, Jiang X, Buragadda S, Newell CJ, Williams MC, Critch AL, Ploughman M. Machine learning classification of multiple sclerosis patients based on raw data from an instrumented walkway. Biomed Eng Online 2022;21:21. [PMID: 35354470 DOI: 10.1186/s12938-022-00992-x] [Reference Citation Analysis]
30 Pardo G, Coates S, Okuda DT. Outcome measures assisting treatment optimization in multiple sclerosis. J Neurol 2021. [PMID: 34338857 DOI: 10.1007/s00415-021-10674-8] [Reference Citation Analysis]
31 Ghai S, Ghai I. Effects of Rhythmic Auditory Cueing in Gait Rehabilitation for Multiple Sclerosis: A Mini Systematic Review and Meta-Analysis. Front Neurol 2018;9:386. [PMID: 29942278 DOI: 10.3389/fneur.2018.00386] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
32 Signoriello E, Bonavita S, Di Pietro A, Abbadessa G, Rossi F, Miele G, Casertano S, Lus G. BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab. Multiple Sclerosis and Related Disorders 2020;43:102186. [DOI: 10.1016/j.msard.2020.102186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
33 Smith VM, Varsanik JS, Walker RA, Russo AW, Patel KR, Gabel W, Phillips GA, Kimmel ZM, Klawiter EC. Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system. Mult Scler J Exp Transl Clin 2018;4:2055217317753465. [PMID: 29383266 DOI: 10.1177/2055217317753465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
34 LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC). The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability. Mult Scler 2018;24:1469-84. [PMID: 28799444 DOI: 10.1177/1352458517723718] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
35 Koch MW, Metz L, Cutter G. An enrichment strategy for clinical trials in SPMS. Mult Scler 2021;27:1884-93. [PMID: 33404355 DOI: 10.1177/1352458520983584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Supratak A, Datta G, Gafson AR, Nicholas R, Guo Y, Matthews PM. Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis. Front Neurol 2018;9:561. [PMID: 30057565 DOI: 10.3389/fneur.2018.00561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
37 Motl RW, Sandroff BM, McAuley E. Naturally occurring change in Multiple Sclerosis Walking Scale-12 scores over time in multiple sclerosis. Neurodegener Dis Manag 2018;8:315-22. [PMID: 30226109 DOI: 10.2217/nmt-2018-0016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Radecka A, Knyszyńska A, Łuczak J, Lubkowska A. Adaptive changes in muscle activity after cryotherapy treatment: Potential mechanism for improvement the functional state in patients with multiple sclerosis. NeuroRehabilitation 2021;48:119-31. [PMID: 33386821 DOI: 10.3233/NRE-201535] [Reference Citation Analysis]
39 Mueller C, Baird JF, Motl RW. Whole-Brain Metabolic Abnormalities Are Associated With Mobility in Older Adults With Multiple Sclerosis. Neurorehabil Neural Repair 2022;:15459683221076461. [PMID: 35164595 DOI: 10.1177/15459683221076461] [Reference Citation Analysis]
40 Weller D, Lörincz L, Sutter T, Reuter K, Linnebank M, Weller M, Zörner B, Filli L. Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis. J Neurol Sci 2020;416:116978. [PMID: 32559515 DOI: 10.1016/j.jns.2020.116978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Macaron G, Ontaneda D. Diagnosis and Management of Progressive Multiple Sclerosis. Biomedicines 2019;7:E56. [PMID: 31362384 DOI: 10.3390/biomedicines7030056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
42 Snow NJ, Wadden KP, Chaves AR, Ploughman M. Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research. Neural Plast 2019;2019:6430596. [PMID: 31636661 DOI: 10.1155/2019/6430596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Rao SM, Galioto R, Sokolowski M, McGinley M, Freiburger J, Weber M, Dey T, Mourany L, Schindler D, Reece C, Miller DM, Bethoux F, Bermel RA, Williams JR, Levitt N, Phillips GA, Rhodes JK, Alberts J, Rudick RA. Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules. Eur J Neurol 2020;27:878-86. [PMID: 32009276 DOI: 10.1111/ene.14162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
44 Barbado D, Gomez-Illan R, Moreno-Navarro P, Valero-Conesa G, Reina R, Vera-Garcia FJ. Postural control quantification in minimally and moderately impaired persons with multiple sclerosis: The reliability of a posturographic test and its relationships with functional ability. J Sport Health Sci 2020;9:677-84. [PMID: 33308819 DOI: 10.1016/j.jshs.2018.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Abasıyanık Z, Yiğit P, Özdoğar AT, Kahraman T, Ertekin Ö, Özakbaş S. A comparative study of the effects of yoga and clinical Pilates training on walking, cognition, respiratory functions, and quality of life in persons with multiple sclerosis: A quasi-experimental study. Explore (NY) 2021;17:424-9. [PMID: 32855074 DOI: 10.1016/j.explore.2020.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Almuklass AM, Davis L, Hamilton LD, Hebert JR, Alvarez E, Enoka RM. Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized Trial. Neurorehabil Neural Repair 2018;32:84-93. [PMID: 29366377 DOI: 10.1177/1545968317753681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
47 Tommasin S, De Giglio L, Ruggieri S, Petsas N, Giannì C, Pozzilli C, Pantano P. Relation between functional connectivity and disability in multiple sclerosis: a non-linear model. J Neurol 2018;265:2881-92. [PMID: 30276520 DOI: 10.1007/s00415-018-9075-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
48 Bergsland N, Benedict RHB, Dwyer MG, Fuchs TA, Jakimovski D, Schweser F, Tavazzi E, Weinstock-Guttman B, Zivadinov R. Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study. J Magn Reson Imaging 2021;53:731-9. [PMID: 33044013 DOI: 10.1002/jmri.27389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Koch MW, Mostert JP, Uitdehaag B, Cutter G. A comparison of clinical outcomes in PPMS in the INFORMS original trial data set. Mult Scler 2021;27:1864-74. [PMID: 33464149 DOI: 10.1177/1352458520987539] [Reference Citation Analysis]
50 Feasel CD, Sandroff BM, Motl RW. Aerobic reserve capacity in multiple sclerosis-Preliminary evidence. Acta Neurol Scand 2021;144:260-5. [PMID: 33914899 DOI: 10.1111/ane.13441] [Reference Citation Analysis]
51 Shah VV, McNames J, Mancini M, Carlson-Kuhta P, Spain RI, Nutt JG, El-Gohary M, Curtze C, Horak FB. Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson's disease and matched controls during daily living. J Neurol 2020;267:1188-96. [PMID: 31927614 DOI: 10.1007/s00415-020-09696-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
52 Weller D, Filli L, Meyer C, Lörincz L, Linnebank M, Weller M, Curt A, Zörner B. Impaired speed-dependent modulation of the gait pattern in multiple sclerosis. J Neurol 2020;267:2998-3007. [PMID: 32500374 DOI: 10.1007/s00415-020-09965-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Podda J, Pedullà L, Monti Bragadin M, Piccardo E, Battaglia MA, Brichetto G, Bove M, Tacchino A. Spatial constraints and cognitive fatigue affect motor imagery of walking in people with multiple sclerosis. Sci Rep 2020;10:21938. [PMID: 33318605 DOI: 10.1038/s41598-020-79095-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Mamoei S, Jensen HB, Dalgas U, Zijdewind I, Pedersen AK, Nygaard MKE, Eskildsen SF, Stenager E. A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis - An explorative study. J Clin Neurosci 2020;82:179-85. [PMID: 33317729 DOI: 10.1016/j.jocn.2020.10.034] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Koch MW, Kaur S, Sage K, Kim J, Levesque-Roy M, Cerchiaro G, Yong VW, Cutter GR, Metz LM. Hydroxychloroquine for Primary Progressive Multiple Sclerosis. Ann Neurol 2021;90:940-8. [PMID: 34590328 DOI: 10.1002/ana.26239] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Mahdavi KD, Jordan SE, Barrows HR, Pravdic M, Habelhah B, Evans NE, Blades RB, Iovine JJ, Becerra SA, Steiner RA, Chang M, Kesari S, Bystritsky A, O'Connor E, Gross H, Pereles FS, Whitney M, Kuhn T. Treatment of Dementia With Bosutinib: An Open-Label Study of a Tyrosine Kinase Inhibitor. Neurol Clin Pract 2021;11:e294-302. [PMID: 34484904 DOI: 10.1212/CPJ.0000000000000918] [Reference Citation Analysis]
57 Koch MW, Mostert J, Repovic P, Bowen JD, Uitdehaag B, Cutter G. Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis. Neurology 2021;96:e111-20. [PMID: 33106389 DOI: 10.1212/WNL.0000000000011123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Rasche L, Scheel M, Otte K, Althoff P, van Vuuren AB, Gieß RM, Kuchling J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU, Schmitz-Hübsch T. MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study. Front Neurol 2018;9:718. [PMID: 30210439 DOI: 10.3389/fneur.2018.00718] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
59 Motl RW, Backus D, Neal WN, Cutter G, Palmer L, Mcburney R, Schmidt H, Bethoux F, Hebert J, Ng A, Mccully KK, Plummer P. Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis. Contemporary Clinical Trials 2019;81:110-22. [DOI: 10.1016/j.cct.2019.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
60 Ibrahim AA, Flachenecker F, Gaßner H, Rothammer V, Klucken J, Eskofier BM, Kluge F. Short inertial sensor-based gait tests reflect perceived state fatigue in multiple sclerosis. Multiple Sclerosis and Related Disorders 2022;58:103519. [DOI: 10.1016/j.msard.2022.103519] [Reference Citation Analysis]
61 Pauwels A, Van Schependom J, Devolder L, Van Remoortel A, Nagels G, Bjerke M, D’hooghe MB. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis. Mult Scler. [DOI: 10.1177/13524585221094224] [Reference Citation Analysis]
62 Nicodemus NE, Becerra S, Kuhn TP, Packham HR, Duncan J, Mahdavi K, Iovine J, Kesari S, Pereles S, Whitney M, Mamoun M, Franc D, Bystritsky A, Jordan S. Focused transcranial ultrasound for treatment of neurodegenerative dementia. Alzheimers Dement (N Y) 2019;5:374-81. [PMID: 31440580 DOI: 10.1016/j.trci.2019.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
63 Barclay A, Paul L, Macfarlane N, Mcfadyen A. The effect of cycling using active-passive trainers on spasticity, cardiovascular fitness, function and quality of life in people with moderate to severe Multiple Sclerosis (MS); a feasibility study. Multiple Sclerosis and Related Disorders 2019;34:128-34. [DOI: 10.1016/j.msard.2019.06.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
64 Trentzsch K, Weidemann ML, Torp C, Inojosa H, Scholz M, Haase R, Schriefer D, Akgün K, Ziemssen T. The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice. Front Neurosci 2020;14:582046. [PMID: 33192268 DOI: 10.3389/fnins.2020.582046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Mamoei S, Jensen HB, Pedersen AK, Nygaard MKE, Eskildsen SF, Dalgas U, Stenager E. Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis-An Explorative Study. Front Neurol 2021;12:758710. [PMID: 34764932 DOI: 10.3389/fneur.2021.758710] [Reference Citation Analysis]
66 Motl RW, Sandroff BM, Benedict RH, Hubbard EA, Pilutti LA, Sutton BP. Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis? Mult Scler 2021;27:401-9. [PMID: 32228278 DOI: 10.1177/1352458520914822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Peeters LM, van Munster CE, Van Wijmeersch B, Bruyndonckx R, Lamers I, Hellings N, Popescu V, Thalheim C, Feys P. Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done! Mult Scler 2019;25:500-9. [PMID: 30381984 DOI: 10.1177/1352458518807076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Meca-Lallana V, Berenguer-Ruiz L, Carreres-Polo J, Eichau-Madueño S, Ferrer-Lozano J, Forero L, Higueras Y, Téllez Lara N, Vidal-Jordana A, Pérez-Miralles FC. Deciphering Multiple Sclerosis Progression. Front Neurol 2021;12:608491. [PMID: 33897583 DOI: 10.3389/fneur.2021.608491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hiew S, Nguemeni C, Zeller D. Efficacy of transcranial direct current stimulation in people with multiple sclerosis: a review. Eur J Neurol 2021. [PMID: 34725881 DOI: 10.1111/ene.15163] [Reference Citation Analysis]
70 Drużbicki M, Guzik A, Przysada G, Phd LP, Brzozowska-Magoń A, Cygoń K, Boczula G, Bartosik-Psujek H. Effects of Robotic Exoskeleton-Aided Gait Training in the Strength, Body Balance, and Walking Speed in Individuals With Multiple Sclerosis: A Single-Group Preliminary Study. Arch Phys Med Rehabil 2021;102:175-84. [PMID: 33181115 DOI: 10.1016/j.apmr.2020.10.122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Jakimovski D, Bergsland N, Dwyer MG, Traversone J, Hagemeier J, Fuchs TA, Ramasamy DP, Weinstock-Guttman B, Benedict RHB, Zivadinov R. Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients. Front Neurol 2020;11:700. [PMID: 32765407 DOI: 10.3389/fneur.2020.00700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Edwards EM, Daugherty AM, Nitta M, Atalla M, Fritz NE. Backward walking sensitively detects fallers in persons with multiple sclerosis. Multiple Sclerosis and Related Disorders 2020;45:102390. [DOI: 10.1016/j.msard.2020.102390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Roura E, Maclair G, Andorrà M, Juanals F, Pulido-Valdeolivas I, Saiz A, Blanco Y, Sepulveda M, Llufriu S, Martínez-Heras E, Solana E, Martinez-Lapiscina EH, Villoslada P. Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients. Neuroimage Clin 2021;30:102653. [PMID: 33838548 DOI: 10.1016/j.nicl.2021.102653] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Rocca MA, Comi G, Filippi M. The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. Front Neurol 2017;8:433. [PMID: 28928705 DOI: 10.3389/fneur.2017.00433] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
75 Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN. [The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:110-9. [PMID: 31934996 DOI: 10.17116/jnevro201911910110] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Creagh AP, Lipsmeier F, Lindemann M, Vos M. Interpretable deep learning for the remote characterisation of ambulation in multiple sclerosis using smartphones. Sci Rep 2021;11:14301. [PMID: 34253769 DOI: 10.1038/s41598-021-92776-x] [Reference Citation Analysis]
77 Devasahayam AJ, Chaves AR, Lasisi WO, Curtis ME, Wadden KP, Kelly LP, Pretty R, Chen A, Wallack EM, Newell CJ, Williams JB, Kenny H, Downer MB, McCarthy J, Moore CS, Ploughman M. Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study. BMC Neurol 2020;20:33. [PMID: 31969132 DOI: 10.1186/s12883-020-1611-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Bollaert RE, Poe K, Hubbard EA, Motl RW, Pilutti LA, Johnson CL, Sutton BP. Associations of functional connectivity and walking performance in multiple sclerosis. Neuropsychologia 2018;117:8-12. [DOI: 10.1016/j.neuropsychologia.2018.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
79 Johansson S, Ytterberg C, Gottberg K, Holmqvist LW, von Koch L, Conradsson D. Participation in social/lifestyle activities in people with multiple sclerosis: Changes across 10 years and predictors of sustained participation. Mult Scler 2020;26:1775-84. [DOI: 10.1177/1352458519881991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
80 Hibner BA, Hilgenkamp TIM, Schroeder EC, Motl RW, Bollaert RE, Griffith G, Grigoriadis G, Baynard T, Fernhall B. Physical activity and peak oxygen consumption are associated with walking in multiple sclerosis. Mult Scler Relat Disord 2020;40:101941. [PMID: 31954226 DOI: 10.1016/j.msard.2020.101941] [Reference Citation Analysis]
81 Yap SM, Etzelmueller MS, O'Keeffe C, Gaughan M, Kearney H, Tubridy N, Reilly RB, McGuigan C. Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials. Mult Scler Relat Disord 2021;52:102946. [PMID: 33901968 DOI: 10.1016/j.msard.2021.102946] [Reference Citation Analysis]
82 W Koch M, Mostert J, Repovic P, Bowen JD, Strijbis E, Uitdehaag B, Cutter G. Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS. Mult Scler 2021;:13524585211063623. [PMID: 34965774 DOI: 10.1177/13524585211063623] [Reference Citation Analysis]
83 Cohen JA, Hunter SF, Brown TR, Gudesblatt M, Thrower BW, Llorens L, Souza-Prien CJ, Ruby AE, Chernoff DN, Patni R. Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial. Mult Scler 2019;25:601-9. [PMID: 29368539 DOI: 10.1177/1352458518754716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
84 van 't Hullenaar CAA, Coerver E, Kalkers NF, van Kempen Z, Koch M, Uitdehaag BMJ, Killestein J, Strijbis EMM. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis. Mult Scler Relat Disord 2021;55:103165. [PMID: 34404022 DOI: 10.1016/j.msard.2021.103165] [Reference Citation Analysis]
85 Holtzer R, Ross D, Izzetoglu M. Intraindividual variability in neural activity in the prefrontal cortex during active walking in older adults. Psychol Aging 2020;35:1201-14. [PMID: 33180518 DOI: 10.1037/pag0000583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Knox KB, Clay L, Stuart-Kobitz K, Nickel D. Perspectives on walking from people with multiple sclerosis and reactions to video self-observation. Disabil Rehabil 2020;42:211-8. [PMID: 30348030 DOI: 10.1080/09638288.2018.1496154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Krajnc N, Berger T, Bsteh G. Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment Options. Biomolecules 2021;11:1342. [PMID: 34572555 DOI: 10.3390/biom11091342] [Reference Citation Analysis]
88 Bradshaw MJ, Farrow S, Motl RW, Chitnis T. Wearable biosensors to monitor disability in multiple sclerosis. Neurol Clin Pract 2017;7:354-62. [PMID: 29185551 DOI: 10.1212/CPJ.0000000000000382] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
89 Monaghan AS, Huisinga JM, Peterson DS. The application of principal component analysis to characterize gait and its association with falls in multiple sclerosis. Sci Rep 2021;11:12811. [PMID: 34140612 DOI: 10.1038/s41598-021-92353-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Thrue C, Riemenschneider M, Hvid L, Stenager E, Dalgas U. Time matters: Early-phase multiple sclerosis is accompanied by considerable impairments across multiple domains. Mult Scler 2021;27:1477-85. [DOI: 10.1177/1352458520936231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Martínez-López I, Maurino J, Sanmartín-Fenollera P, Ontañon-Nasarre A, Santiago-Pérez A, Moya-Carmona I, García-Collado CG, Fernández-Del Olmo R, García-Arcelay E, Sarmiento M, Carreño Á, Pérez-Encinas M. Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis. Pharmacy (Basel) 2020;8:E61. [PMID: 32272683 DOI: 10.3390/pharmacy8020061] [Reference Citation Analysis]
92 Riemenschneider M, Hvid LG, Ringgaard S, Nygaard MKE, Eskildsen SF, Petersen T, Stenager E, Dalgas U. Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open 2021;11:e043699. [PMID: 33436475 DOI: 10.1136/bmjopen-2020-043699] [Reference Citation Analysis]
93 Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 2019;15:329-42. [PMID: 31000816 DOI: 10.1038/s41582-019-0183-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 36.5] [Reference Citation Analysis]
94 Koch MW, Mostert J, Repovic P, Bowen JD, Wolinsky JS, Lublin FD, Strijbis E, Cutter G. Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis. Eur J Neurol 2021. [PMID: 34927308 DOI: 10.1111/ene.15220] [Reference Citation Analysis]
95 Jeng B, Sandroff BM, Motl RW. Energetic cost of walking and spasticity in persons with multiple sclerosis with moderate disability. NeuroRehabilitation 2018;43:483-9. [PMID: 30400119 DOI: 10.3233/NRE-182498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
96 Bollaert RE, Sandroff BM, Stine-Morrow EAL, Sutton BP, Motl RW. The Intersection of Physical Function, Cognitive Performance, Aging, and Multiple Sclerosis: A Cross-sectional Comparative Study. Cogn Behav Neurol 2019;32:1-10. [PMID: 30896571 DOI: 10.1097/WNN.0000000000000179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
97 Mardaniyan Ghahfarrokhi M, Banitalebi E, Faramarzi M, Motl R. Feasibility and efficacy of home-based neurofunctional exercise vs. resistance exercise programs for ambulatory disability of multiple sclerosis patients with cognitive impairment. Multiple Sclerosis and Related Disorders 2021. [DOI: 10.1016/j.msard.2021.103400] [Reference Citation Analysis]
98 Liman J, Wolff von Gudenberg A, Baehr M, Paulus W, Neef NE, Sommer M. Enlarged Area of Mesencephalic Iron Deposits in Adults Who Stutter. Front Hum Neurosci 2021;15:639269. [PMID: 33643015 DOI: 10.3389/fnhum.2021.639269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Saleh S, Sandroff BM, Vitiello T, Owoeye O, Hoxha A, Hake P, Goverover Y, Wylie G, Yue G, Deluca J. The Role of Premotor Areas in Dual Tasking in Healthy Controls and Persons With Multiple Sclerosis: An fNIRS Imaging Study. Front Behav Neurosci 2018;12:296. [DOI: 10.3389/fnbeh.2018.00296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
100 Shema-Shiratzky S, Hillel I, Mirelman A, Regev K, Hsieh KL, Karni A, Devos H, Sosnoff JJ, Hausdorff JM. A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity. J Neurol 2020;267:1912-21. [PMID: 32166481 DOI: 10.1007/s00415-020-09759-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
101 Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 2020;19:860-71. [PMID: 32949546 DOI: 10.1016/S1474-4422(20)30277-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 18.5] [Reference Citation Analysis]
102 Buttolph L, Corn J, Hanes D, Bradley R, Senders A. Community qigong for People with Multiple Sclerosis: A Pragmatic Feasibility Study. J Altern Complement Med 2021;27:506-14. [PMID: 33769837 DOI: 10.1089/acm.2020.0481] [Reference Citation Analysis]
103 Koch MW, Mostert J, Repovic P, Bowen JD, Comtois J, Strijbis E, Uitdehaag B, Cutter G. The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset. J Neurol. [DOI: 10.1007/s00415-022-11171-2] [Reference Citation Analysis]
104 Fox RJ, Kryscio RJ. A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis. Neurology 2021;96:833-4. [PMID: 34038382 DOI: 10.1212/WNL.0000000000011862] [Reference Citation Analysis]
105 Rochester L, Mazzà C, Mueller A, Caulfield B, McCarthy M, Becker C, Miller R, Piraino P, Viceconti M, Dartee WP, Garcia-Aymerich J, Aydemir AA, Vereijken B, Arnera V, Ammour N, Jackson M, Hache T, Roubenoff R. A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. Digit Biomark 2020;4:13-27. [PMID: 33442578 DOI: 10.1159/000512513] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
106 Cohen JA, Cameron MH, Goldman MD, Goodman AD, Miller AE, Rollins A, Llorens L, Patni R, Elfont R, Johnson R. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Mult Scler 2021;:13524585211035333. [PMID: 34449295 DOI: 10.1177/13524585211035333] [Reference Citation Analysis]
107 Costa SL, Deluca J, Costanza K, Chiaravalloti ND. Comparing the Open Trial – Selective Reminding Test results with the California Learning Verbal Test II in multiple sclerosis. Applied Neuropsychology: Adult 2018;26:488-96. [DOI: 10.1080/23279095.2018.1448818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Uitdehaag BMJ. Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis. CNS Drugs 2018;32:543-58. [PMID: 29926371 DOI: 10.1007/s40263-018-0530-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
109 Khalifeloo M, Naghdi S, Ansari NN, Dommerholt J, Sahraian MA. Dry needling for the treatment of muscle spasticity in a patient with multiple sclerosis: a case report. Physiother Theory Pract 2021;:1-7. [PMID: 34546842 DOI: 10.1080/09593985.2021.1978118] [Reference Citation Analysis]
110 Cohen JN, Seng E, Foley FW. Cognitive and motor slowing mediate the relationship between depression and falls in multiple sclerosis patients. Mult Scler Relat Disord 2021;50:102808. [PMID: 33596493 DOI: 10.1016/j.msard.2021.102808] [Reference Citation Analysis]
111 Zhan J, Yakimov V, Rühling S, Fischbach F, Nikolova E, Joost S, Kaddatz H, Greiner T, Frenz J, Holzmann C, Kipp M. High Speed Ventral Plane Videography as a Convenient Tool to Quantify Motor Deficits during Pre-Clinical Experimental Autoimmune Encephalomyelitis. Cells 2019;8:E1439. [PMID: 31739589 DOI: 10.3390/cells8111439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
112 Sikes EM, Cederberg KL, Sandroff BM, Bartolucci A, Motl RW. Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis. Arch Phys Med Rehabil 2020;101:524-34. [PMID: 31669296 DOI: 10.1016/j.apmr.2019.08.488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
113 Frechette ML, Meyer BM, Tulipani LJ, Gurchiek RD, Mcginnis RS, Sosnoff JJ. Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis. Curr Neurol Neurosci Rep 2019;19. [DOI: 10.1007/s11910-019-0997-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
114 Brier MR, Snyder AZ, Tanenbaum A, Rudick RA, Fisher E, Jones S, Shimony JS, Cross AH, Benzinger TLS, Naismith RT. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability. Ann Clin Transl Neurol 2021;8:1096-109. [PMID: 33943045 DOI: 10.1002/acn3.51354] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Grobelny A, Behrens JR, Mertens S, Otte K, Mansow-Model S, Krüger T, Gusho E, Bellmann-Strobl J, Paul F, Brandt AU, Schmitz-Hübsch T. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing. PLoS One 2017;12:e0189281. [PMID: 29244874 DOI: 10.1371/journal.pone.0189281] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
116 Koch MW, Mostert J, Repovic P, Bowen JD, Strijbis E, Uitdehaag B, Cutter G. Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset. J Neurol 2021. [PMID: 34392376 DOI: 10.1007/s00415-021-10750-z] [Reference Citation Analysis]
117 Sotiropoulos MG, Lokhande H, Healy BC, Polgar-Turcsanyi M, Glanz BI, Bakshi R, Weiner HL, Chitnis T. Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability. Mult Scler J Exp Transl Clin 2021;7:20552173211015503. [PMID: 34104471 DOI: 10.1177/20552173211015503] [Reference Citation Analysis]
118 Woelfle T, Pless S, Wiencierz A, Kappos L, Naegelin Y, Lorscheider J. Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study. J Med Internet Res 2021;23:e30394. [PMID: 34792480 DOI: 10.2196/30394] [Reference Citation Analysis]
119 van Munster CE, D'Souza M, Steinheimer S, Kamm CP, Burggraaff J, Diederich M, Kravalis K, Dorn J, Walsh L, Dahlke F, Kappos L, Uitdehaag BM. Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis. Mult Scler 2019;25:1673-81. [PMID: 30168739 DOI: 10.1177/1352458518796690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Sandroff BM, Silveira SL, Baird JF, Huynh T, Motl RW. Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis. Phys Ther 2021;101:pzaa227. [PMID: 33373454 DOI: 10.1093/ptj/pzaa227] [Reference Citation Analysis]
121 Simmons SB, Schippling S, Giovannoni G, Ontaneda D. Predicting disability worsening in relapsing and progressive multiple sclerosis. Curr Opin Neurol 2021;34:312-21. [PMID: 33709974 DOI: 10.1097/WCO.0000000000000928] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Hernandez L, O'Donnell M, Postma M; for MSOAC. Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies. Pharmacoeconomics 2021;39:243-56. [PMID: 32989685 DOI: 10.1007/s40273-020-00964-w] [Reference Citation Analysis]
123 Moumdjian L, Maes PJ, Dalla Bella S, Decker LM, Moens B, Feys P, Leman M. Detrended fluctuation analysis of gait dynamics when entraining to music and metronomes at different tempi in persons with multiple sclerosis. Sci Rep 2020;10:12934. [PMID: 32737347 DOI: 10.1038/s41598-020-69667-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Edwards T, Motl RW, Sebastião E, Pilutti LA. Pilot randomized controlled trial of functional electrical stimulation cycling exercise in people with multiple sclerosis with mobility disability. Multiple Sclerosis and Related Disorders 2018;26:103-11. [DOI: 10.1016/j.msard.2018.08.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
125 Liparoti M, Della Corte M, Rucco R, Sorrentino P, Sparaco M, Capuano R, Minino R, Lavorgna L, Agosti V, Sorrentino G, Bonavita S. Gait abnormalities in minimally disabled people with Multiple Sclerosis: A 3D-motion analysis study. Multiple Sclerosis and Related Disorders 2019;29:100-7. [DOI: 10.1016/j.msard.2019.01.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
126 Akbar N, Sandroff BM, Wylie GR, Strober LB, Smith A, Goverover Y, Motl RW, DeLuca J, Genova H. Progressive resistance exercise training and changes in resting-state functional connectivity of the caudate in persons with multiple sclerosis and severe fatigue: A proof-of-concept study. Neuropsychol Rehabil 2020;30:54-66. [PMID: 29618280 DOI: 10.1080/09602011.2018.1449758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
127 Vecchio D, Varrasi C, Virgilio E, Spagarino A, Naldi P, Cantello R. Cannabinoids in multiple sclerosis: A neurophysiological analysis. Acta Neurol Scand 2020;142:333-8. [PMID: 32632918 DOI: 10.1111/ane.13313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
128 Shema-Shiratzky S, Gazit E, Sun R, Regev K, Karni A, Sosnoff JJ, Herman T, Mirelman A, Hausdorff JM. Deterioration of specific aspects of gait during the instrumented 6-min walk test among people with multiple sclerosis. J Neurol 2019;266:3022-30. [PMID: 31493037 DOI: 10.1007/s00415-019-09500-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
129 Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-guttman B, Motl R, Benedict RH. Dalfampridine benefits ambulation but not cognition in multiple sclerosis. Mult Scler 2020;26:91-8. [DOI: 10.1177/1352458518815795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
130 Jahren SE, Aakvaag N, Strisland F, Vogl A, Liberale A, Liverud AE. Towards Human Motion Tracking Enhanced by Semi-Continuous Ultrasonic Time-of-Flight Measurements. Sensors (Basel) 2021;21:2259. [PMID: 33804840 DOI: 10.3390/s21072259] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Ehling R, Bsteh G, Muehlbacher A, Hermann K, Brenneis C. Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis. PLoS One 2019;14:e0220613. [PMID: 31369622 DOI: 10.1371/journal.pone.0220613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Koch MW, Mostert J, Uitdehaag B, Cutter G. Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets. Mult Scler 2020;26:1540-9. [DOI: 10.1177/1352458519876701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
133 Sandroff BM, Bollaert RE, Pilutti LA, Peterson ML, Baynard T, Fernhall B, Mcauley E, Motl RW. Multimodal exercise training in multiple sclerosis: A randomized controlled trial in persons with substantial mobility disability. Contemporary Clinical Trials 2017;61:39-47. [DOI: 10.1016/j.cct.2017.07.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
134 Gil-Bermejo-Bernardez-Zerpa A, Moral-Munoz JA, Lucena-Anton D, Luque-Moreno C. Effectiveness of Motor Imagery on Motor Recovery in Patients with Multiple Sclerosis: Systematic Review. Int J Environ Res Public Health 2021;18:E498. [PMID: 33435410 DOI: 10.3390/ijerph18020498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Cheng W, Bourke AK, Lipsmeier F, Bernasconi C, Belachew S, Gossens C, Graves JS, Montalban X, Lindemann M. U-turn speed is a valid and reliable smartphone-based measure of multiple sclerosis-related gait and balance impairment. Gait & Posture 2021;84:120-6. [DOI: 10.1016/j.gaitpost.2020.11.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
136 Koch MW, Sage K, Kaur S, Kim J, Cerchiaro G, Yong VW, Cutter GR, Metz LM. Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial. Neurology 2021;96:e2313-22. [PMID: 34038379 DOI: 10.1212/WNL.0000000000011863] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Van Geel F, Veldkamp R, Severijns D, Dalgas U, Feys P. Day-to-day reliability, agreement and discriminative validity of measuring walking-related performance fatigability in persons with multiple sclerosis. Mult Scler 2020;26:1785-9. [PMID: 31496362 DOI: 10.1177/1352458519872465] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
138 Moumdjian L, Six J, Veldkamp R, Geys J, Van Der Linden C, Goetschalckx M, Van Nieuwenhoven J, Bosmans I, Leman M, Feys P. Embodied learning in multiple sclerosis using melodic, sound, and visual feedback: a potential rehabilitation approach. Ann N Y Acad Sci 2022. [PMID: 35437776 DOI: 10.1111/nyas.14777] [Reference Citation Analysis]
139 Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD. Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence. Neurology International 2022;14:423-36. [DOI: 10.3390/neurolint14020035] [Reference Citation Analysis]
140 Baird JF, Cutter GR, Motl RW. Do Physical Activity, Cardiorespiratory Fitness, and Subcortical Brain Structures Explain Reduced Walking Performance in Older Adults with Multiple Sclerosis? Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103702] [Reference Citation Analysis]
141 Sandroff BM, Diggs MD, Bamman MM, Cutter GR, Baird JF, Jones CD, Rinker JR, Wylie GR, DeLuca J, Motl RW. Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis. Contemp Clin Trials 2019;87:105878. [PMID: 31704437 DOI: 10.1016/j.cct.2019.105878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
142 Demir S. Multiple Sclerosis Functional Composite. Noro Psikiyatr Ars 2018;55:S66-8. [PMID: 30692860 DOI: 10.29399/npa.23349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
143 Nguemeni C, Hiew S, Kögler S, Homola GA, Volkmann J, Zeller D. Split-Belt Training but Not Cerebellar Anodal tDCS Improves Stability Control and Reduces Risk of Fall in Patients with Multiple Sclerosis. Brain Sciences 2022;12:63. [DOI: 10.3390/brainsci12010063] [Reference Citation Analysis]
144 Marrie RA, Cutter GR, Fox RJ, Vollmer T, Tyry T, Salter A. NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights. Int J MS Care 2021;23:276-84. [PMID: 35035299 DOI: 10.7224/1537-2073.2020-133] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Alenazy M, Daneshgar Asl S, Petrigna L, Feka K, Alvarez E, Almuklass AM, Enoka RM. Treatment with electrical stimulation of sensory nerves improves motor function and disability status in persons with multiple sclerosis: A pilot study. J Electromyogr Kinesiol 2021;61:102607. [PMID: 34710779 DOI: 10.1016/j.jelekin.2021.102607] [Reference Citation Analysis]
146 Zörner B, Hostettler P, Meyer C, Killeen T, Gut P, Linnebank M, Weller M, Straumann D, Filli L. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103802] [Reference Citation Analysis]
147 Shi J, Wu X, Chen Y. Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis. PLoS One 2019;14:e0222288. [PMID: 31513613 DOI: 10.1371/journal.pone.0222288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
148 Callesen J, Richter C, Kristensen C, Sunesen I, Næsby M, Dalgas U, Skjerbæk AG. Test–retest agreement and reliability of the Six Spot Step Test in persons with multiple sclerosis. Mult Scler 2019;25:286-94. [DOI: 10.1177/1352458517745725] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
149 D'Souza M, Papadopoulou A, Girardey C, Kappos L. Standardization and digitization of clinical data in multiple sclerosis. Nat Rev Neurol 2021;17:119-25. [PMID: 33452493 DOI: 10.1038/s41582-020-00448-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Bollaert RE, Motl RW. Self-efficacy and Physical and Cognitive Function in Older Adults with Multiple Sclerosis. Int J MS Care 2019;21:63-9. [PMID: 31049036 DOI: 10.7224/1537-2073.2018-001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Miller Renfrew L, Lord AC, McFadyen AK, Rafferty D, Hunter R, Bowers R, Mattison P, Moseley O, Paul L. A comparison of the initial orthotic effects of functional electrical stimulation and ankle-foot orthoses on the speed and oxygen cost of gait in multiple sclerosis. J Rehabil Assist Technol Eng 2018;5:2055668318755071. [PMID: 31191925 DOI: 10.1177/2055668318755071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]